Search Login Register

G(M2) Ganglioside (Ganglioside GM2) Summary

Description: A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B (BETA-N-ACETYLHEXOSAMINIDASES), or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE.

Also Known As: Ganglioside GM2; GM2, Ganglioside; Ganglioside, Tay-Sachs Disease; Tay Sachs Disease Ganglioside; Tay-Sachs Disease Ganglioside

Networked: 179 relevant articles (5 outcomes, 17 trials/studies) for this Bio-Agent

Key Diseases for which G(M2) Ganglioside is Relevant

  1. Melanoma (Melanoma, Malignant) : 4 outcomes 6 studies in 22 results
  2. Lung Neoplasms (Lung Cancer) : 1 outcome 2 studies in 7 results
  3. Neoplasm Metastasis (Metastasis) : 1 outcome 1 study in 5 results
  4. Neoplasms (Cancer) : 4 studies in 24 results
  5. Sandhoff Disease (Sandhoff's Disease) : 1 study in 43 results
Show All >>

Drugs Related to G(M2) Ganglioside

  1. Antibodies
  2. Antigens
  3. Immunoglobulin M (IgM)
  4. QS 21 (QS21)
  5. Hexosaminidase A (Hex A)
  6. Proteins (Proteins, Gene)
  7. Saponins
  8. Interferon-gamma (Interferon, gamma)
  9. Hemocyanin
  10. Doxorubicin (Adriamycin)
Show All >>

Therapies Related to G(M2) Ganglioside

  1. Caloric Restriction
  2. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  3. Immunotherapy

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.